Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 1
1998 2
1999 2
2000 5
2001 10
2002 10
2003 5
2004 13
2005 19
2006 19
2007 16
2008 10
2009 13
2010 4
2011 4
2012 6
2013 4
2014 2
2015 2
2016 1
2017 1
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11333452

146 results
Results by year
Filters applied: . Clear all
Page 1
Tumour necrosis factor blockade in rheumatoid arthritis.
Breedveld FC. Breedveld FC. Clin Med (Lond). 2001 Mar-Apr;1(2):107-9. doi: 10.7861/clinmedicine.1-2-107. Clin Med (Lond). 2001. PMID: 11333452 Free PMC article. Review. No abstract available.
Anti-TNF agents for rheumatoid arthritis.
Seymour HE, Worsley A, Smith JM, Thomas SH. Seymour HE, et al. Br J Clin Pharmacol. 2001 Mar;51(3):201-8. doi: 10.1046/j.1365-2125.2001.00321.x. Br J Clin Pharmacol. 2001. PMID: 11298065 Free PMC article. Review.
Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
Vandevyvere K, Luyten FP, Verschueren P, Lories R, Segaert S, Westhovens R. Vandevyvere K, et al. Clin Rheumatol. 2007 Dec;26(12):2205-2206. doi: 10.1007/s10067-007-0733-8. Epub 2007 Sep 18. Clin Rheumatol. 2007. PMID: 17876646 No abstract available.
Which TNF inhibitor for rheumatoid arthritis?
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 May 17;52(1338):38-9. Med Lett Drugs Ther. 2010. PMID: 20467356 No abstract available.
[Infliximab for therapy of rheumatoid arthritis].
Amano K. Amano K. Nihon Rinsho. 2005 Jan;63 Suppl 1:517-20. Nihon Rinsho. 2005. PMID: 15799410 Review. Japanese. No abstract available.
Infliximab: a new treatment for rheumatoid arthritis.
Emery P. Emery P. Hosp Med. 2001 Mar;62(3):150-2. doi: 10.12968/hosp.2001.62.3.1534. Hosp Med. 2001. PMID: 11291464 Review.
146 results
Jump to page
Feedback